Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank21
3Y CAGR-4.5%
5Y CAGR-1.6%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
-4.5%/yr
vs -0.4%/yr prior
5Y CAGR
-1.6%/yr
Consistent
Acceleration
-4.1pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $63.81M | -16.0% |
| 2024 | $76.00M | -7.9% |
| 2023 | $82.53M | +12.7% |
| 2022 | $73.22M | -11.7% |
| 2021 | $82.94M | +20.2% |
| 2020 | $69.03M | -19.6% |
| 2019 | $85.86M | +15.6% |
| 2018 | $74.28M | -13.7% |
| 2017 | $86.06M | +8.4% |
| 2016 | $79.35M | - |